{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T13:14:17Z","timestamp":1775826857924,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"PTC Therapeutics International Ltd"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Duchenne muscular dystrophy is a rare genetic neuromuscular disorder, which can result in early death due to disease progression. Ataluren is indicated for the treatment of nonsense mutation Duchenne muscular dystrophy, in ambulatory individuals aged two years and older. This study explored the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy, as well as the impact of treatment with ataluren on the caregiver experience, using retrospective recall.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Qualitative interviews were conducted with caregivers in the UK. Interviews were conducted by telephone, were recorded and transcribed. Data were analysed using thematic analysis and saturation was recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Ten interviews were conducted with parents of individuals aged 4\u201319\u2009years. Caregivers reported proximal impacts (physical, emotional, time-related), and distal impacts (work, relationships, social life) of caring for their sons. The relationships between these impacts were illustrated in a conceptual model. Changes to the caregiver experience since initiation with their son\u2019s treatment were discussed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy has a substantial multifaceted impact on caregivers. Treatments which have the potential to improve symptoms or delay progression, may also have a positive impact on the quality of life of caregivers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41687-021-00344-8","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T09:03:38Z","timestamp":1628586218000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A qualitative study on the impact of caring for an ambulatory individual with nonsense mutation Duchenne muscular dystrophy"],"prefix":"10.1186","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4874-0334","authenticated-orcid":false,"given":"Kate","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Rance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Buesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Acaster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"344_CR1","first-page":"687","volume-title":"Lancet. Elsevier Limited","author":"AEH Emery","year":"2002","unstructured":"Emery, A. E. H. (2002). The muscular dystrophies. In Lancet. Elsevier Limited, (pp. 687\u2013695)."},{"issue":"1","key":"344_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","volume":"12","author":"S Ryder","year":"2017","unstructured":"Ryder, S., Leadley, R. M., Armstrong, N., Westwood, M., de Kock, S., Butt, T., \u2026 Kleijnen, J. (2017). The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: An evidence review. Orphanet J Rare Dis, 12(1), 79. https:\/\/doi.org\/10.1186\/s13023-017-0631-3.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"344_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-020-01430-8","volume":"15","author":"S Crisafulli","year":"2020","unstructured":"Crisafulli, S., Sultana, J., Fontana, A., Salvo, F., Messina, S., & Trifir\u00f2, G. (2020). Global epidemiology of Duchenne muscular dystrophy: An updated systematic review and meta-analysis. Orphanet J Rare Dis, 15(1), 141. https:\/\/doi.org\/10.1186\/s13023-020-01430-8.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"344_CR4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/mt.2011.59","volume":"19","author":"C Pichavant","year":"2011","unstructured":"Pichavant, C., Aartsma-Rus, A., Clemens, P. R., Davies, K. E., Dickson, G., Takeda, S.'., \u2026 Tremblay, J. P. (2011). Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol Ther, 19(5), 830\u2013840. https:\/\/doi.org\/10.1038\/mt.2011.59.","journal-title":"Mol Ther"},{"key":"344_CR5","volume-title":"Translarna, INN-ataluren. ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS","author":"EMA","year":"2014","unstructured":"EMA (2014) Translarna, INN-ataluren. ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS"},{"issue":"10","key":"344_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/dmcn.13934","volume":"60","author":"E Landfeldt","year":"2018","unstructured":"Landfeldt, E., Edstr\u00f6m, J., Buccella, F., Kirschner, J., & Lochm\u00fcller, H. (2018). Duchenne muscular dystrophy and caregiver burden: A systematic review. Dev Med Child Neurol, 60(10), 987\u2013996. https:\/\/doi.org\/10.1111\/dmcn.13934.","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"344_CR7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11136-019-02355-x","volume":"29","author":"SM Szabo","year":"2020","unstructured":"Szabo, S. M., Audhya, I. F., Malone, D. C., Feeny, D., & Gooch, K. L. (2020). Characterizing health state utilities associated with Duchenne muscular dystrophy: A systematic review. Qual Life Res, 29(3), 593\u2013605. https:\/\/doi.org\/10.1007\/s11136-019-02355-x.","journal-title":"Qual Life Res"},{"issue":"12","key":"344_CR8","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3109\/09638288.2011.628738","volume":"34","author":"RF Pangalila","year":"2012","unstructured":"Pangalila, R. F., Van Den Bos, G. A. M., Stam, H. J., et al. (2012). Subjective caregiver burden of parents of adults with Duchenne muscular dystrophy. Disabil Rehabil, 34(12), 988\u2013996. https:\/\/doi.org\/10.3109\/09638288.2011.628738.","journal-title":"Disabil Rehabil"},{"issue":"Suppl 1","key":"344_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10198-016-0782-5","volume":"17","author":"M Cavazza","year":"2016","unstructured":"Cavazza, M., Kodra, Y., Armeni, P., et al. (2016). Social\/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe. Eur J Health Econ, 17(Suppl 1), 19\u201329. https:\/\/doi.org\/10.1007\/s10198-016-0782-5.","journal-title":"Eur J Health Econ"},{"issue":"5","key":"344_CR10","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s00415-016-8080-9","volume":"263","author":"E Landfeldt","year":"2016","unstructured":"Landfeldt, E., Lindgren, P., Bell, C. F., Guglieri, M., Straub, V., Lochm\u00fcller, H., & Bushby, K. (2016a). Quantifying the burden of caregiving in Duchenne muscular dystrophy. J Neurol, 263(5), 906\u2013915. https:\/\/doi.org\/10.1007\/s00415-016-8080-9.","journal-title":"J Neurol"},{"issue":"5","key":"344_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/dmcn.12938","volume":"58","author":"E Landfeldt","year":"2016","unstructured":"Landfeldt, E., Lindgren, P., Bell, C. F., Guglieri, M., Straub, V., Lochm\u00fcller, H., & Bushby, K. (2016b). Health-related quality of life in patients with Duchenne muscular dystrophy: A multinational, cross-sectional study. Dev Med Child Neurol, 58(5), 508\u2013515. https:\/\/doi.org\/10.1111\/dmcn.12938.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"344_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejpn.2010.07.006","volume":"15","author":"J Read","year":"2011","unstructured":"Read, J., Kinali, M., Muntoni, F., Weaver, T., & Garralda, M. E. (2011). Siblings of young people with Duchenne muscular dystrophy - a qualitative study of impact and coping. Eur J Paediatr Neurol, 15(1), 21\u201328. https:\/\/doi.org\/10.1016\/j.ejpn.2010.07.006.","journal-title":"Eur J Paediatr Neurol"},{"issue":"7","key":"344_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1080\/09638288.2017.1408148","volume":"41","author":"M Yamaguchi","year":"2019","unstructured":"Yamaguchi, M., Sonoda, E., & Suzuki, M. (2019). The experience of parents of adult sons with Duchenne muscular dystrophy regarding their prolonged roles as primary caregivers: A serial qualitative study. Disabil Rehabil, 41(7), 746\u2013752. https:\/\/doi.org\/10.1080\/09638288.2017.1408148.","journal-title":"Disabil Rehabil"},{"key":"344_CR14","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.jval.2020.04.069","volume":"23","author":"E Crossley","year":"2020","unstructured":"Crossley, E., Chandler, F., Godfrey, J., Fischer, R., Furlong, P., Abrams, K., \u2026 Powell, P. A. (2020). PB4 project HERCULES: A patient led paradigm in evidence generation for HTA in DUCHENNE muscular dystrophy. Value Heal, 23, S13. https:\/\/doi.org\/10.1016\/j.jval.2020.04.069.","journal-title":"Value Heal"},{"issue":"1","key":"344_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1468794107085301","volume":"8","author":"GA Bowen","year":"2008","unstructured":"Bowen, G. A. (2008). Naturalistic inquiry and the saturation concept: A research note. Qual Res, 8(1), 137\u2013152. https:\/\/doi.org\/10.1177\/1468794107085301.","journal-title":"Qual Res"},{"issue":"3","key":"344_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1586\/erp.10.30","volume":"10","author":"C Kerr","year":"2010","unstructured":"Kerr, C., Nixon, A., & Wild, D. (2010). Assessing and demonstrating data saturation in qualitative inquiry supporting patientreported outcomes research. Expert Rev Pharmacoeconomics Outcomes Res, 10(3), 269\u2013281. https:\/\/doi.org\/10.1586\/erp.10.30.","journal-title":"Expert Rev Pharmacoeconomics Outcomes Res"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-021-00344-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-021-00344-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-021-00344-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T09:06:59Z","timestamp":1628586419000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-021-00344-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["344"],"URL":"https:\/\/doi.org\/10.1186\/s41687-021-00344-8","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"assertion":[{"value":"9 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the WIRB-Copernicus Group Independent Review Board (tracking number: #20193514).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All participants provided verbal informed consent at the start of the interviews.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Kate Williams and Sarah Acaster are employees of Acaster Lloyd Consulting Ltd. Katharina Buesch, Ian Davidson and Mark Rance are employees of PTC Therapeutics.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}